Merck & Co., Inc.
Symbol: MRK (NYSE)
87.70
▲ (0.09%) 0.081
Company Description:
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Key Stats
- Today's Open: $87.68
- Today's High: $88.75
- Today's Low: $87.042
- Today's Volume: 10.93M
- Yesterday Close: $87.62
- Yesterday High: $87.67
- Yesterday Low: $86.23
- Yesterday Volume: 9.85M
- Last Min Volume: 0
- Last Min High: $87.725
- Last Min Low: $87.701
- Last Min VWAP: $0
Company Profile
- Name: Merck & Co., Inc.
- Website: https://www.merck.com
- Listed Date: 1949-04-20
- Location: RAHWAY, NJ
- Market Status: Active
- CIK Number: 0000310158
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $218.86B
- Round Lot: 100
- Outstanding Shares: 2.50B
- Asset Type: CS
RECENT FILINGS FOR MRK
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-09-09 | 8-K | View |
| 2025-09-04 | 424B5 | View |
| 2025-09-03 | FWP | View |
| 2025-09-02 | 424B5 | View |
| 2025-08-13 | 13F-HR | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-07-29 | 8-K | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-06-27 | 11-K | View |
| 2025-06-27 | 11-K | View |
| 2025-06-27 | 11-K | View |
| 2025-06-03 | 4 | View |
| 2025-06-03 | 4 | View |
Latest News on MRK